Clinical Trials Sponsored by MD Anderson Cancer Center Orlando

Total 3641 results

Omar Mahmoud

Not yet recruiting

Dose Adjusted Chemoradiotherapy in HPV-Associated Oropharynx Cancer of the Elderly ((DACHOC-E))

Frailty | Oropharynx Cancer
Orlando Immunology Center

Recruiting

A Pharmacist-run PrEP Program for Women (OPTIMIZE)

HIV Prevention

United States
Charlotte-Paige Rolle, MD
ViiV Healthcare

Completed

Efficacy of Switching to DTG/3TC in Virologically-suppressed Adults Currently on B/F/TAF (DYAD)

HIV I Infection

United States
Orlando Immunology Center
GlaxoSmithKline

Completed

Evolution of L74V or K65R Mutations in VIremic Subjects on Tenofovir Disoproxil Fumarate (TDF) or Abacavir (ABC) (EVITA)

HIV Infections

United States
Orlando VA Medical Center

Unknown

Multi-dose Ibuprofen Prophylaxis for IUD-insertion (MIPI)

Pelvic Pain | IUD

United States
Orlando Regional Medical Center

Completed

The LOOP Trial in Treatment of Skin Abscesses

Abscess
Orlando Regional Medical Center

Completed

Percutaneous Catheter Decompression in the Treatment of Elevated Intra-abdominal Pressure

Compartment Syndromes

United States
Orlando VA Medical Center

Recruiting

Photobiomodulation for Myofascial Pelvic Pain (PMPP)

Pelvic Pain | Levator Ani Syndrome | Chronic Pelvic Pain Syndrome | Spastic Pelvic Floor Syndrome | Myalgia of Pelvic Floor

United States
M.D. Anderson Cancer Center

Recruiting

Goals of Care Discussion for Patients With Advanced Lung and Gastrointestinal Cancer in the Emergency Department of a Comprehensive Cancer Center

Lung Cancer | Gastrointestinal Cancer

United States
M.D. Anderson Cancer Center

Not yet recruiting

18F-AraG PET/CT as a Non-Invasive Imaging Biomarker for Chemoradiation Treatment Response in Esophageal Cancer

Esophageal Cancer

United States
M.D. Anderson Cancer Center

Not yet recruiting

Phase II Study of REPotrectinib With or Without Fulvestrant in Patients With Hormone Receptor-positive Human Epidermal Growth Factor 2-negative Metastatic Invasive LObular Carcinoma Who Received a Prior Endocrine Therapy in Combination With Cyclin-dependent Kinase 4 and 6 Inhibitor (REPLOT Trial)

Hormone Receptor-positive Human Epidermal Growth Factor 2-negative | Metastatic Invasive LObular Carcinoma

United States
M.D. Anderson Cancer Center

Recruiting

Psycho-Spiritual Management for Patients With Advanced Cancer and Their Family Caregivers

Cancer

United States
M.D. Anderson Cancer Center

Not yet recruiting

Establishing a Tumor Registry of Patients With Mesonephric-like Adenocarcinoma (MLA)

Mesonephric-like Adenocarcinoma

United States
M.D. Anderson Cancer Center

Not yet recruiting

A Randomized Phase II Basket Trial EXTENDing Efficacy of Systemic Therapy With Local Consolidative Therapy for OligoProgressive Metastatic Disease (EXTEND-OP)

OligoProgressive Metastatic Disease

United States
M.D. Anderson Cancer Center

Not yet recruiting

Open-label Phase 2 Study of Avutometinib (RAF/MEK Clamp) in Combination With Defactinib (FAK Inhibitor) and Cetuximab in Patients With Unresectable, Anti-EGFR-Refractory Advanced Colorectal Cancer

Advanced Colorectal Cancer

United States
M.D. Anderson Cancer Center

Not yet recruiting

Structured Personalized Oxygen and Supportive Therapies for Dyspnea in Oncology

Dyspnea

United States
M.D. Anderson Cancer Center

Not yet recruiting

Validation of the Screen of Cancer Survivorship - Occupational Therapy Services (SOCS-OTS) Tool for Use in a Physical Medicine Rehabilitation Clinic

Cancer | Occupational Therapy

United States
M.D. Anderson Cancer Center

Not yet recruiting

Hypophysectomy by Stereotactic Radiosurgery for Cancer-Related Pain

Hypophysectomy

United States
M.D. Anderson Cancer Center

Not yet recruiting

Phase Ib/II Study Assessing the Clinical Activity and Safety of Brexucabtagene Autoleucel as a Consolidation in Patients With Relapsed/Refractory (R/R) and Newly Diagnosed B-cell Acute Lymphocytic Leukemia (ALL) Post Cytoreduction With Mini-HCVD-inotuzumab-blinatumomab/HCVAD-inotuzumab-blinatumomab

B-cell Acute Lymphocytic Leukemia | Relapsed/Refractory

United States
M.D. Anderson Cancer Center

Not yet recruiting

Phase II Study of Pirtobrutinib, Rituximab (PR) in Previously Untreated Low and Intermediate Risk MCL (Mantle Cell Lymphoma) Patients

Mantle Cell Lymphoma

United States
M.D. Anderson Cancer Center

Not yet recruiting

Low-Dose Sirolimus to Increase Hematopoietic Function in Patients With RUNX1 Familial Platelet Disorder

Familial Platelet Disorder | Hematopoietic

United States
M.D. Anderson Cancer Center

Recruiting

5x-Multiplier vs 3-Tier Model for Discharge Opioid Prescriptions After Intra-abdominal Cancer Surgery: A Randomized Clinical Trial

Intra-abdominal Cancer

United States
M.D. Anderson Cancer Center

Recruiting

Pilot Trial of Fecal Microbiota Transplantation for Lymphoma Patients Receiving Axicabtagene Ciloleucel Therapy.

Lymphoma

United States
M.D. Anderson Cancer Center

Not yet recruiting

Radiologic Pathologic Correlation of Imaging to Distinguish True Progression From Pseudoprogression in Brain Malignancies

Brain Malignancies | Pseudoprogression

United States
M.D. Anderson Cancer Center

Recruiting

Effect of Olanzapine on Opioid Craving and Misuse Among Patients Receiving Opioids for Cancer-related Pain: A Pilot Double-Blind, Randomized Control Trial

Misuse, Opioid

United States
M.D. Anderson Cancer Center

Recruiting

Serologic Response to Pneumococcal Vaccination Among Esophageal Cancer Patients With High Grade Lymphopenia After Chemoradiation

Esophageal Cancer | Chemoradiation | Lymphopenia | Pneumococcal Vaccine

United States
M.D. Anderson Cancer Center

Recruiting

Phase II Randomized-registry Embedded Study of Lymphoscintigraphy for Oropharyngeal Neoplasms to Enable Risk-adapted Nodal Guidance for Robotic Surgery and/or Radiotherapy (LONE-RANGR2)

Oropharyngeal Neoplasms | Robotic Surgery and/or Radiotherapy | Lymphoscintigraphy

United States
M.D. Anderson Cancer Center

Recruiting

Methylnatrexone In Resectable Head and Neck Squamous Cell Carcinoma (MINK). A "Window of Opportunity" Pilot Study.

Head and Neck Squamous Cell Carcinoma

United States
M.D. Anderson Cancer Center

Recruiting

A Pilot Presurgical Trial of REGN5678 (Anti-PSMA x CD28) in Patients With High-risk, Localized Prostate Cancer Followed by Radical Prostatectomy

Prostate Cancer | Radical Prostatectomy

United States
M.D. Anderson Cancer Center

Recruiting

Minimally-invasive Stabilization of Pelvic Metastases With Photodynamic Nails: A Multi-center Prospective Study of Functional Outcome

Pelvic Metastasis

United States
M.D. Anderson Cancer Center

Recruiting

A Phase III Randomized Trial Comparing Stereotactic Body Radiation Therapy (SBRT) vs Conventional Palliative Radiation Therapy for Painful Bone Metastases

Bone Metastases

United States
M.D. Anderson Cancer Center

Recruiting

A Phase II Study of Axicabtagene Ciloleucel, an Anti-CD19 Chimeric Antigen Receptor (CAR) Tcell Therapy, in Combination With Radiotherapy (RT) in Relapsed/Refractory Follicular Lymphoma

Follicular Lymphoma

United States
M.D. Anderson Cancer Center

Recruiting

Immunogenicity and Clinical Efficacy of 20-valent Pneumococcal Conjugate Vaccine (PCV20) in Lymphoma Survivors After Treatment With Anti-CD20 Therapy

Lymphoma

United States
M.D. Anderson Cancer Center

Recruiting

A Single-Arm Study of Pembrolizumab With Gemcitabine and Cisplatin as Perioperative Therapy for Potentially Resectable Intrahepatic Cholangiocarcinoma

Cholangiocarcinoma

United States
M.D. Anderson Cancer Center

Recruiting

Reminder Messages for Lung Cancer Screening

Lung Cancer | Skin Flaps

United States
M.D. Anderson Cancer Center

Recruiting

A Prospective Feasibility Study Using ctDNA to Tailor Neoadjuvant Chemotherapy for Patients With Colorectal or Appendiceal Adenocarcinoma

Colorectal | Appendiceal Adenocarcinoma

United States
M.D. Anderson Cancer Center

Recruiting

An Evaluation of the Implementation of the Care and Monitoring at Home Program- A New Paradigm for Acute Care Management of Cancer Patients

Cancer

United States
M.D. Anderson Cancer Center

Recruiting

Comprehensive Monitoring of Men With Prostate Cancer Cared for by "Active Surveillance

Prostate Cancer

United States
M.D. Anderson Cancer Center

Recruiting

A Phase Ib Trial of Azacitidine, Venetoclax and Allogeneic NK Cells for Acute Myeloid Leukemia (ADVENT-AML)

Acute Myeloid Leukemia

United States
M.D. Anderson Cancer Center

Recruiting

A Randomized Trial Comparing a Ventilatory Strategy To Prevent Atelectasis Versus a Lateral Decubitus Strategy During Robotic Bronchoscopy (VESPA vs. LADS Trial)

Lung | Pulmonary

United States
M.D. Anderson Cancer Center

Recruiting

Phase II Cohort of Spinal Stereotactic Radiotherapy in Patients Using a MR LINAC

Spinal Disease

United States
M.D. Anderson Cancer Center

Recruiting

Perceptions of Hospital Care at Home for Patients With Cancer: A Qualitative Study of Cancer Providers, Patients and Caregivers.

Cancer

United States
M.D. Anderson Cancer Center

Recruiting

Connecting Black Families in Houston, Texas to Hereditary Cancer Genetic Counseling, Genetic Testing, and Cascade Testing by Using a Simple Genetic Risk Screening Tool and Telegenetics

Breast Cancer | Colorectal Cancer

United States
M.D. Anderson Cancer Center

Recruiting

A Phase II Trial of Mosunetuzumab, Polatuzumab, Tafasitamab, and Lenalidomide in Patients With Relapsed B-cell NHL

Hodgkin Lymphoma | B-Cell Lymphoma | Relapsed B-cell NHL

United States
M.D. Anderson Cancer Center

Recruiting

Phase 1b/2 Trial of Ipilimumab, Nivolumab, and Ciforadenant (Adenosine A2a Receptor Antagonist) in First-line Advanced Renal Cell Carcinoma.

Renal Cell Carcinoma

United States
M.D. Anderson Cancer Center

Recruiting

Temporal Immunologic Changes With Hypofractionated Radiation-Induced DNA Damage in Breast Cancer

Breast Carcinoma | Invasive Breast Carcinoma

United States
M.D. Anderson Cancer Center

Recruiting

A Phase II Study of the Combination of Azacitidine and Pembrolizumab for Patients Relapsed/Refractory Hodgkin's Lymphoma

Hodgkin's Lymphoma

United States
M.D. Anderson Cancer Center

Recruiting

Phase II Trial of Immunotherapy in Patients With Carcinomas Arising From the Renal Medulla

Renal Medullary Carcinoma | Carcinomas

United States
M.D. Anderson Cancer Center

Recruiting

First-in-Human Assessment of Safety, Biodistribution and Pharmacokinetics of 18F-Fluoro-1-Naphthol (18F-4FN) for PET Imaging

Endocrine Neoplasia

United States
M.D. Anderson Cancer Center

Recruiting

Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study

Ovarian Cancer | Fallopian Tube Cancer

United States

3

Subscribe